Abstract Experience sampling methodology (ESM) was used in a randomized controlled trial of short-term therapy to examine changes in daily affect and reactivity to daily event appraisals among depressed patients. Fifty-five depressed adults (mean age 37 years, 80 % female) were randomly assigned to one of two therapy conditions. Using an interactive voice response system, participants rated activities and emotional functioning eight times per day for 7 days. Twenty-nine participants completed treatment and repeated ESM at post-treatment. Broad improvements in mood, cognition, and physical functioning were similar across treatment conditions, with the largest improvements for markers of positive affect. Participants demonstrated increased resilience, i.e., diminished reactivity to stressors, at post-treatment. Changes in reactivity to positive daily situations were minimal. Findings underscore the utility of ESM in psychotherapy research and the importance of including measures of both positive and negative affect and experiences.
Introduction
Evaluating the efficacy of psychological interventions for depression typically involves assessments before and after treatment, often with measures inquiring about symptoms over a retrospective period of several days or weeks. For example, the Beck Depression Inventory (Beck et al. 1996) and Patient Health Questionnaire 9-item depression scale (Kroenke et al. 2001) ask about symptoms over the past 2 weeks; the Center for Epidemiological Studies Depression scale (Radloff 1977) covers the past week. The respondents' ratings should reflect ''typical'' symptom levels; however, the accuracy of recalled information has been called into question (Schrader et al. 1990 ).
Experience sampling methodology (ESM) refers to data collection methods in which respondents are assessed during daily life multiple times over days, weeks, or months (Conner et al. 2009 ). Studies using ESM, which asks about in-the-moment experiences, alongside traditional self-reports have shown biases in the retrospective reporting of emotions, particularly when people are asked to produce ''averages'' over days or weeks (Ben-Zeev and Young 2010; Ben-Zeev et al. 2009; Parkinson et al. 1995) . Furthermore, with ESM, researchers can evaluate withinperson variability over shorter time windows. Another important advantage of ESM is that data are collected in the participant's natural environment, allowing for finegrained examination of contextual factors (Ebner-Priemer and Trull 2009) .
One such contextual factor, daily positive and negative events, has been examined in several studies using ESM. Results on reactivity to stressors have varied, with some showing no differences between depressed and control groups (Bylsma et al. 2011 ) and others showing exaggerated negative affect (NA) in clinical depression (Myin-Germeys et al. 2003) , dysphoria, and anxiety (Nezlek and Gable 2001; South and Miller 2014) . One study found that the NA response to stress in depression, while blunted in comparison to controls, was more persistent over time . Regarding positive events, some ESM studies have reported a ''mood brightening'' effect [increase in positive affect (PA) and decrease in NA with positive events] among depressed patients. Bylsma et al. (2011) examined event reactivity and reported that, relative to controls, patients had a greater decrease in NA in response to positive events, with no differences in PA. Using a slightly more severe sample, Peeters and colleagues found larger PA increases and smaller NA decreases in patients .
Regarding treatment effects, ESM is becoming increasingly common in studies for some conditions such as substance abuse (Moore et al. 2014; Tidey et al. 2008) but has been used infrequently with depression. BargeSchaapveld and colleagues used ESM to evaluate the efficacy of antidepressants (Barge-Schaapveld and Nicolson 2002; Barge-Schaapveld et al. 1995; Wichers et al. 2009 ) and found that depressed patients had higher NA responses to stress than controls at baseline, a difference that decreased after 6 weeks of pharmacotherapy. Patients did not differ from controls on PA responses to pleasant events at baseline, but PA responses increased with treatment (Wichers et al. 2009) .
A handful of studies comparing different forms of treatment (without nondepressed controls or a no-treatment group) have been conducted with ESM. Peeters et al. (2010) used 6 days of pre-treatment ESM in an uncontrolled depression treatment study (pharmacotherapy and supportive therapy combined). They found that lower NA in response to negative events in daily life predicted poorer outcomes, interpreted as indicating that a generalized blunting of affective reactivity is associated with poorer prognosis. However, their study did not include a post-treatment ESM assessment, so pre/post changes could not be assessed. Another study (Forbes et al. 2012) used ESM throughout an 8-week treatment in a sample of children and adolescents with depression and anxiety. Treatment conditions were not randomly assigned and included cognitive-behavioral therapy (CBT), pharmacotherapy, or both. They found that ratings of emotion assessed using ESM predicted response to treatment above and beyond retrospective self-report measures. A third study using ESM examined mindfulness-based cognitive therapy (MBCT) as an adjunct to treatment-as-usual in patients with residual depressive. Therapy was associated with increases in PA experiences in general and in response to pleasant events (Geschwind et al. 2011) .
The results from these studies suggest that momentary assessments provide a unique contribution to our understanding of treatment response. They are becoming an increasingly prominent therapeutic tool for clinicians (Naylor et al. 2008; Rose et al. 2012) ; for example, a recent study used ESM-based feedback as an adjunct to treatment as usual (medications and/or psychotherapy) for depression (Hartmann et al. 2015) . However, there have been no studies to our knowledge using ESM to evaluate outcomes in the context of a randomized controlled psychotherapy trial. In the current study, depressed patients were randomly assigned to CBT or self-system therapy (SST). The treatments differed primarily in their proposed mechanisms of action: whereas CBT focuses on restructuring dysfunctional cognitions, SST targets problems with self-regulation-the ability to set, monitor, and successfully pursue personal goals (Vieth et al. 2003) . Previous studies (Eddington et al. 2015; Strauman et al. 2006) showed that the two therapies were equally effective in reducing depressive symptoms using retrospective self-report measures. However, both studies showed that SST was more effective for participants with pre-treatment deficits in self-regulation.
Participants in the Eddington et al. clinical trial completed a week of intensive experience sampling at baseline and during the week preceding the final therapy session. Using a phone-based interactive voice response (IVR) system, participants responded to questions in five domains: mood, cognition, social activity, physical functioning, and activities. Because the two treatments share a common goal of improving emotional functioning and coping (albeit through different means), both should show increases in PA and decreases in NA. Because the ESM items assessed broad domains of functioning (for example, the cognition items tapped into broad aspects of cognition like trouble concentrating rather than treatment-specific ones like cognitive distortions), we did not expect condition-specific effects.
A secondary aim was to examine the extent to which emotional reactivity to daily stressors and positive events changes with treatment. Findings regarding affective blunting and mood brightening notwithstanding, we expected that patients should show decreased NA in response to stress and increased PA in response to positive events. This hypothesis was guided by what the treatments are supposedly doing (improving skills for coping with stress and enhancing focus on pleasant events) and by the handful of studies showing this pattern of change with pharmacotherapy (e.g., Barge-Schaapveld et al. 1995; Wichers et al. 2009 ).
advertisements. Study procedures were approved by an Institutional Review Board and informed consent was obtained from all participants. Demographic characteristics are shown in Table 1 ; for a more detailed review of recruitment procedures and participant flow see Eddington et al. (2015) and Fig. 1 . Inclusion criteria included primary diagnosis of major depressive disorder (MDD) or dysthymia, BDI-II score above 14, no antidepressant medication use for 4 months prior to the study, no active substance use problems for 6 months prior, no history of mania, no history of psychotic symptoms, no diagnosis of antisocial or borderline personality disorders, and no active suicidal intent or immediate threats of self-harm.
Of 100 screened, 56 met inclusion criteria 1 and were assigned to either SST (n = 27) or CBT (n = 29) using restricted randomization. One participant who was randomized to SST but completed only one ESM survey was excluded. Of the 55 participants with baseline ESM data, 29 (15 in SST and 14 in CBT) also completed the posttreatment ESM. Six participants did not initiate any treatment, one participant completed treatment but did not complete post-treatment ESM, and the remaining 19 (34 %) completed at least one therapy session and therefore are considered drop-outs. There were no significant differences on baseline BAI and BDI-II between those who completed or prematurely dropped out of treatment (p's [ .05). Of the 15 ESM items used in the current analyses, only the item, ''My emotions feel out of control right now'' significantly differed at baseline between the two groups using within-person means, t(53) = 4.61, p \ .05. Participants who dropped out of treatment (M = 2.95, SD = 1.26) rated that item somewhat higher on average than completers (M = 2.33, SD = 0.98).
Measures

Semi-structured Clinical Interview for DSM-IV-TR: Research Version
The SCID-I (research version) and SCID-II are semistructured diagnostic interviews for DSM-IV-TR (American Psychiatric Association 2000) Axis I and Axis II disorders, respectively. From the SCID-I, study diagnosticians administered the overview and screening sections, mood modules, anxiety modules, and psychotic symptoms; from the SCID-II, the antisocial and borderline personality modules were used. Additional modules (e.g., substance abuse and dependence, eating disorders) were used as needed based on the participant's responses to the screening items.
Beck Depression Inventory-II
The BDI-II (Beck et al. 1996 ) is a self-report measure of depressive symptom severity during the past 2 weeks that contains 21 items, each rated on a 4-point scale (0-3). The BDI-II has excellent psychometric properties (Dozois et al. 1998) , and internal consistency in this study was good (a = .82).
Beck Anxiety Inventory
The BAI (Beck et al. 1988 ) is a self-report measure of anxiety symptom severity during the past 2 weeks. The scale consists of 21 items, each rated on a 4-point scale (0-3) scale. The BAI has good psychometric properties (Fydrich et al. 1992) ; in this study, internal consistency was very good (a = .95).
Experience Sampling Methodology Items
An interactive voice response system (IVR) was used for ESM data collection. IVR involves the use of a host computer that is programmed to automatically call participants' cell phones and (using pre-recorded voice prompts) asks the participants questions to which they respond using their phone keypad. Participants were prompted via cell phone to complete 31 items assessing aspects of cognition, positive and negative mood, and experience of contextual factors such as activities, physical functioning, social functioning, and stressful situations at the time of the call (Table 2) . Items were not constructed in an attempt to measure unitary constructs. Recognizing the importance of keeping each survey extremely brief in order to minimize participant burden, we tried to avoid redundancy among the items. Items in the ''mood'' category were modeled after items found in many widely-used measures of current mood, such as the Profile of Mood States (Shacham 1983) and Positive and Negative Affect Schedule (Watson et al. 1988) . Participants entered responses using their mobile phone digital keypad.
Procedures
During intake participants provided informed consent in compliance with Institutional Review Board standards, completed the BDI-II and BAI, and (if the BDI-II score was above 14) completed relevant portions of the SCID. Diagnostic interviews were conducted by clinical psychology doctoral students who received training on the administration of the SCID-I and SCID-II. Following 
CONSORT Enrollment Flow Diagram
All participants (n = 29) retained n = 26 retained; one participant with only one ESM survey excluded from analyses completion of the diagnostic interviews, participants were informed of the frequency and duration of ESM calls were given a brief overview of how to use the IVR system (Telesage; www.telesage.com) with their own phone or one provided to them. Participants designated a 12-h window that they preferred to receive calls. The day following intake began their full week of baseline assessment. Baseline and post-treatment intensive ESM data collection employed random-time sampling to signal participants eight times each day for 1 week. The eight calls were randomized within 90 min segments equally separated within each 12-h block. If a participant missed a call, he or she could call the system back within a restricted 10-min period, and responses were all date-and time-stamped. Items and timing parameters were identical at pre-and post-treatment. Upon completion of the baseline ESM, participants were randomly assigned treatment (treatment assignments were unknown to the participants during the baseline ESM week). Details about the two therapy conditions can be found in Eddington et al. (2015) . Briefly, both skills-based treatments involved 16 sessions oriented toward current problems and concerns. Adherence to treatment protocols was assessed through blind coding of therapy session recordings and the two conditions differed in the expected directions (CBT therapists used significantly more CBT strategies; SST therapists used significantly more SST strategies).
Results
Analytic Approach and ESM Compliance
Given the nested structure of the data, our primary analytic approach was multilevel modeling. We estimated the multilevel models with HLM 7, using restricted maximum likelihood with robust standard errors. All items were modeled as continuous except for the item ''Are you alone at this time?'', which was modeled as binary. Unless noted otherwise, all effects are unstandardized.
ESM items were analyzed separately, allowing for a more fine-grained analysis of specific changes from pre-to post-treatment. The use (and analysis) of single face valid items to assess straightforward variables is common practice in ESM research (Barrantes-Vidal et al. 2013; Depp et al. 2012; Fisher and To 2012) For example, a single item was shown to be a valid indicator of fatigue when compared with a multi-item scale (van Hooff et al. 2007) . Within-and between-subjects correlations among the ESM items are available upon request from the corresponding author.
Missing data in experience sampling work is primarily ''signal wise'': people respond to some but not all calls (Silvia et al. 2013) , so people vary in the number of calls they completed. The response rate was good and comparable to past studies with general samples (Burgin et al. ; a difference that was significant t(28) = 3.50, p \ .01. The multilevel models were specified so that the effective sample size was the number of people who completed the first ESM week, so all participants were retained in the analysis regardless of whether they completed a full course of treatment.
Change from Baseline to Post-treatment
To evaluate within-person change from baseline to posttreatment, we estimated a multilevel model for each outcome. For example, the model for change in responses to the item ''I feel happy'' was specified like this:
Time was scored 0 (baseline) and 1 (post), so the model's intercept estimates people's scores at baseline, and the model's slope is the estimated change (in unstandardized, raw units) from baseline to post-treatment. Effects sizes were estimated using the proportional reduction in variance at the within-person level (Raudenbush and Bryk 2002) , using the within-person variance (r ij ) for a null model as the baseline. Table 3 displays the effects. When evaluated in terms of statistical significance, the findings suggest that treatment had a broad effect across a range of measures of functioning. Items in most of the categories showed significant change in the expected direction. Apart from a handful of marginally significant items (including feeling momentarily anxious and overwhelmed), items assessing cognition, PA, NA, evaluations of current activities, and appraisals of the situation were statistically significant. Notably, only the social behavior category showed little change: apart from the item assessing whether people thought they were alone because others didn't want to be with them, none of the social behavior items changed significantly across time.
When evaluated in terms of effect sizes, many items showed substantial change, as shown in Fig. 2. (As a binary outcome, the item ''Are you alone at this time?'' lacks the residual variance needed to compute effect size). As the Proportional Variance Reduction (PVR) column in Table 3 shows, including time as a predictor reduced the unexplained variance by at least 10 % for 12 of the 29 items, and only 5 of 29 items had effects accounting for less than 5 % of the variance. These 5 items primarily involve ratings of current activities. Of note, the effects for the PA items were greater than for the NA items and among the largest effects overall. All 5 of the PA items had effects greater than 10 %, and the item with the single largest effect size-''I feel good about myself,'' at 23 %-reflects positive self-evaluation.
Moderators of Change by Condition
Our next models evaluated whether the rates of change were moderated by treatment condition. As an example of how the moderation models were specified, the model for whether happiness changed more in one condition used this specification:
Treatment condition was scored 0 for CBT and 1 for SST. No statistically significant effects appeared for any of the items. There was one marginal effect for ratings of how close people felt to the people they were with (c = -.68, SE = .38, p = .080), but this interaction was driven by a baseline difference.
2 Overall, this pattern suggests that the broad effects of psychotherapy on functioning were not specific to a particular therapy. Furthermore, this similarity in ESM markers of functioning parallels the findings for the weekly BDI-II and BAI assessments, which showed that the CBT and SST conditions had similar trajectories of change (Eddington et al. 2015) .
Evaluating Affective Reactivity
Our final set of models examined changes in affective reactivity. We estimated two sets of models that examined whether time moderated the effect of being in a stressful situation or in a positive situation on emotions and thoughts. For example, being in a stressful situation should predict feeling overwhelmed, but the strength of the relationship should be weaker after therapy than before. The following equations illustrate such a model:
2 Specifically, at baseline, people who were assigned to CBT had lower values (M = 4.34) than people assigned to SST (M = 4.84), but the means were similar post-treatment (CBT M = 4.78, SST M = 4.60).
Cogn Ther Res (2017) 41:266-277 271 Table 2 for the instructions and response formats for the items. Baseline value is the estimated baseline value; Post-Tx change is the estimated change (slope) from baseline to post treatment. SE and p = standard error and p value for the change. Variance component = the variance component for the change slope, representing the magnitude of between-person heterogeneity in rates of change. Proportional variance reduction = the percentage decline in the within-person residual (r ij ) when time is included as a Level 1 predictor, compared to a null baseline model. ''Are you alone at this time?'' is a binary outcome, so the estimated probabilities of being alone (instead of the log-odds coefficients) are reported for ease of interpretation Stress was measured with the item ''My current situation is stressful'' and was centered at each person's own mean. An interaction term was formed by multiplying the stress scores with time, scored 0 for baseline and 1 for posttreatment. For outcomes, we tested all the items in the Cognition and Affect categories. A similar approach was used for the item ''My current situation is positive.'' For stressful situations, the models revealed statistically significant within-person interactions for most of the items. Specifically, time (baseline to post therapy) significantly moderated the effect of stress on all of the NA items and on the cognition items reflecting having trouble concentrating and ruminating (see Table 4 ). Notably, the effects were relatively specific to NA and experiences. The items associated with PA and thoughts were either marginal or not significant.
All of the significant and marginal interactions indicated improved resilience. For example, Fig. 3 depicts the pattern for the item ''I feel bad about myself right now,'' which is typical for that domain. For each outcome, stress predicted stronger negative experiences. After treatment, however, the slopes between stress and negative experiences became weaker. Treatment thus increased people's resilience in the face of stress: although they viewed the situation as stressful, their thoughts and emotions were less negatively affected.
For positive situations, the models revealed very few statistically significant within-person interactions. As shown in Table 4 , time moderated the effect of positive situations on only two negative items (feeling sad and guilty). Among the positive items, none were even marginally significant. The pattern for these results, illustrated in Fig. 4 for the ''I feel sad'' item, suggests that overall sadness and guilt decreased with treatment and became less affected by being in situations that were less positive.
Discussion
This study is the first to our knowledge to use ESM to assess changes in daily life functioning within the context of a randomized controlled psychotherapy trial for depression. After therapy, participants reported significant improvements in affect and cognitions and (to a lesser extent) social functioning and activities. Consistent with our predictions and with our results using traditional symptom measures (Eddington et al. 2015) , there were no major differences between the two treatment conditions, so our discussion focuses on overall results. Although our primary focus in this study was on changes in daily life emotional experiences and reactivity to events, the ESM protocol assessed daily experiences in a number of domains. Among the ''top 10'' ESM items showing the largest proportional improvements from baseline to post-treatment (see Fig. 2 ), seven reflected increases in PA, positive situational appraisals, and positive aspects of self-concept (i.e., feeling good about oneself) while only three reflected decreases in negative experiences. In general, participants showed significant improvements in mood in the expected directions (increases in PA; decreases in NA). Self-reported daily anxiety (as well as feeling overwhelmed), however, did not change significantly from pre-to post-treatment. Given that the treatments were focused on depression, the limited impact on anxiety may not be surprising. Analyses using traditional, weekly symptom measures did show improvements in anxiety in this sample, although the effects were smaller compared to those for weekly measures of depression (Eddington et al. 2015) .
We were also able to examine within-person interactions between situational appraisals and momentary affect and cognition. It is notable that, in terms of proportional variance reduction, the items characterizing the current situation showed the most stability during treatment. Only modest improvements in situational appraisals (e.g., stressfulness, and liking what one is doing) were observed. However, significant improvement in negative reactivity (affect and cognitions) to stress occurred, consistent with previous ESM results showing similar improvements with medications (Wichers et al. 2009 ). After treatment participants felt less anxious, sad, and irritable under stress, and they reported less rumination and lower levels of feeling bad about themselves. This improvement was more dramatic under high (versus low) stress conditions. This pattern is not surprising-therapy cannot necessarily reduce the frequency of negative events but can improve the ability to cope. Previous studies are mixed concerning the extent to which depressed individuals show heightened baseline stress reactivity compared to controls (Bylsma et al. 2011; Myin-Germeys et al. 2003; Nezlek and Gable 2001; South and Miller 2014) . However, our results The coefficients represent within-person interactions between time (0 = baseline, 1 = post-treatment) and ratings of the current situation (within-person centered). b = unstandardized regression weight; SE = standard error; p = p value. The full item wording is shown in Table 1 * p \ .05 Fig. 3 The within-person interaction of time, stressful situations, and feeling bad about oneself Fig. 4 The within-person interaction of time, positive situations, and feeling sad suggest that differences in negative cognitions and affect that are observed in higher versus lower stress situations are attenuated after therapy. Because our study did not include a nondepressed group, we cannot evaluate the extent to which that change reflects a normalization of response.
What about affective changes in the context of positive situations? Participants did show improvement in the extent to which they perceived their current situation as positive, however, reactivity to those positive situations did not show substantial change. There was some improvement in the extent to which people felt sad and guilty in positive situations, but there was no change in PA or cognition. To the extent that there may be a mood brightening effect in depression (Bylsma et al. 2011) , this effect does not appear to be enhanced with therapy. However, the increase in perceptions that one's current situation is positive may suggest that, by post-treatment, patients have increased the range of their daily activities and have more opportunities to experience PA in daily life.
Regarding changes in the cognitive domain, we saw moderate improvements in thought content at post-treatment, characterized by more pleasant thoughts and less guilt; improvement in rumination was marginal. The difficulty in reducing rumination with CBT has been noted previously (Watkins et al. 2011) , and SST does not specifically target rumination. Interventions that focus on rumination as a treatment target may be associated with greater improvements in that domain (Watkins et al. 2011) . The item assessing difficulties concentrating showed significant change with treatment but, in effect size terms, relatively little improvement. This finding is consistent with research showing that nonspecific cognitive impairments in depressed patients tend to be persistent (Reppermund et al. 2009; Roca et al. 2015) .
Compliance with ESM procedures was variable but comparable to studies with clinical and nonclinical samples (Johnson et al. 2009; Silvia et al. 2013) . Our procedures were rigorous compared to paper-and-pencil methods in that our participants had a narrow response window (10 min), and we could accurately verify the timing of responses using the IVR system. At post-treatment, for those who completed treatment, the mean response rate dropped, but the distribution of response rates at posttreatment shows that over half of the participants completed at least two-thirds of the surveys.
The generalizability of these findings may be limited due both to the small sample size and the fact that ESM is demanding and may attract more motivated participants (Palmier-Claus et al. 2011 ). Additionally, not all participants completed treatment, and therefore we have posttreatment ESM data on only a subset of the full sample. Our drop-out rate of 34 % is on the higher end of, but comparable to, rates reported in other depression treatment studies (Hans and Hiller 2013) , suggesting that the ESM procedures did not necessarily adversely impact retention. Furthermore, of the 56 participants allocated to treatment, only one was excluded for completing only a single ESM survey and 49 (88 %) returned for a first treatment session. Finally, a limitation inherent in ESM studies is the need to reduce participant burden; as such, each phone survey had to be extremely brief. To cover a broad array of domains, we relied on single item assessments.
The use of momentary assessment tools allows for more fine-grained analyses of variability in daily functioning and contextual factors and are less subject to retrospective reporting biases that may influence responses to traditional symptom measures. Although this study yielded both momentary and summative data (i.e., BDI-II scores), the varying time intervals between measurements as well as missing data complicate analyses aimed at determining the extent to which those measures correspond, especially given the small sample size.
In the current study we found that brief, structured psychotherapy was associated with increases in PA and experiences, decreases in NA and experiences, and improvements in stress reactivity in daily life. We did not find differential effects in the two treatment condition, which may be due in part to the small sample size. However, this lack of differentiation may reflect a common mechanism of change, a notion that is consistent with transdiagnostic models of mood and anxiety disorders. For example, a recent transdiagnostic model of mood and anxiety disorders proposes that affective experiences (increased positive and decreased negative affect) and emotion regulation are central to these disorders, and effective treatments are those that enhance the ability to cope with NA (e.g., stress reactivity) and enhance affective experiences (increase PA and decrease NA) (Hofmann et al. 2012) . Our pattern of results is certainly consistent with this notion.
As advances in the technology supporting experience sampling methods continues to improve, the potential of these methods for exploring even more sophisticated questions, such as those about psychotherapy process and mechanisms of action, will become increasingly apparent. In addition, future studies should also evaluate the potential therapeutic effects of intensive daily monitoring procedures, such as those used in the current study.
